H F Eichenwald, G H McCracken. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Aminoglycosides/therapeutic useAnti-Bacterial Agents/therapeutic useBacitracin/therapeutic useBacterial Infections/drug therapyBacterial Infections/prevention & controlCephalosporins/therapeutic useChildChild, PreschoolChloramphenicol/therapeutic useClindamycin/therapeutic useDrug CombinationsDrug Therapy, CombinationErythromycin/therapeutic useHumansInfantKidney Diseases/drug therapyLincomycin/therapeutic useNalidixic Acid/therapeutic useNitrofurans/therapeutic useOxolinic Acid/therapeutic usePenicillin ResistancePenicillins/therapeutic usePolymyxins/therapeutic useRifampin/therapeutic useSulfamethoxazole/therapeutic useSulfonamides/therapeutic useTetracyclines/therapeutic useTrimethoprim/therapeutic useVancomycin/therapeutic use
Substances: See more » AminoglycosidesAnti-Bacterial AgentsCephalosporinsDrug CombinationsNitrofuransPenicillinsPolymyxinsSulfonamidesTetracyclinesBacitracinNalidixic AcidClindamycinErythromycinChloramphenicolVancomycinTrimethoprimLincomycinSulfamethoxazoleOxolinic AcidRifampin
Year: 1978 PMID: 211213 DOI: 10.1016/s0022-3476(78)81139-1
Source DB: PubMed Journal: J Pediatr ISSN: 0022-3476 Impact factor: 4.406